Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Enhancing the path to clinic with an end-to-end solution that addresses supply chain, regulatory, and robust manufacturing processes for viral vectors.
Learn more about a true end-to-end offering for AAV and LV vector manufacturing